Sunday 18 October 2026
Export CYAD’s income statement to Excel — free account
Celyad SA
CYAD Healthcare Biotechnology
Celyad SA’s revenue for fiscal 2025 (year ended December 2025) was $23,800.00, down 88.2% from fiscal 2024.
Follow CYAD
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Piotroski F-Score |
3 | 1 | 5 | 2 | 2 | — | — | — | — | 3 |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
1.34 | (8.09) | (5.82) | (1.52) | (4.55) | — | — | (71.28) | (121.07) | (270.29) |
P/Operating CF |
0.00 | 0.00 | 0.00 | (6.37) | (3.44) | — | — | — | — | — |
Beneish M-Score |
1,404.45 | (4.41) | (2.31) | 2,846.91 | (2.43) | — | — | — | (2.97) | 10.49 |
P/B ratio |
0.00 | 0.00 | 0.00 | 3.94 | 3.07 | — | — | — | — | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 19.08 | 0.00 | — | — | — | — | — |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
EV/Operating CF |
0.97 | 0.32 | 0.50 | (1.63) | (0.94) | — | — | — | — | — |
EV/FCF |
0.93 | 0.31 | 0.49 | (1.60) | (0.94) | — | — | — | — | — |
Quick Ratio |
7.45 | 4.30 | 5.19 | 3.49 | 1.52 | 2.32 | 1.30 | 3.31 | 1.76 | 1.35 |
Current Ratio |
7.57 | 4.58 | 5.36 | 3.59 | 1.67 | 2.48 | 1.42 | 3.79 | 2.29 | 1.92 |
Net Debt/EBITDA |
3.38 | 0.75 | 1.31 | 1.33 | 0.97 | 1.14 | 2.84 | 0.80 | 0.64 | (1.62) |
Debt/Assets |
0.81% | 1.31% | 1.23% | 3.56% | 3.88% | 2.16% | 0.60% | 5.54% | 7.68% | 0.00% |
Debt/Equity |
0.01 | 0.02 | 0.02 | 0.07 | 0.08 | 0.04 | 0.03 | 0.14 | 1.49 | 0.00 |
Asset Turnover |
0.06 | 0.03 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
Operating CF/Net income |
1.05 | 0.79 | 0.73 | 0.99 | 1.61 | 1.00 | 0.68 | 1.80 | 0.98 | (8.31) |
Capex/Depreciation |
(1.12) | (0.10) | (1.52) | (0.35) | (0.05) | (0.26) | (0.09) | 0.51 | (0.23) | 17.48 |
Interest Coverage |
(123.70) | (11.87) | (615.83) | (84.19) | (39.14) | (103.49) | (29.16) | (100.69) | (49.22) | 13.77 |
| (23.29%) | (82.62%) | (74.05%) | (54.94%) | (45.44%) | (72.08%) | (153.55%) | (160.82%) | (170.87%) | 56.72% | |
| (15.80%) | (52.82%) | (44.40%) | (30.26%) | (22.32%) | (36.89%) | (74.78%) | (47.63%) | (44.44%) | 12.04% | |
ROIC |
(169.87%) | (225.64%) | (340.22%) | (190.46%) | (65.05%) | (107.45%) | 0.00% | (2,616.94%) | 0.00% | 75.63% |
Return on Tangible Assets |
(30.40%) | (177.68%) | (83.06%) | (79.59%) | (143.49%) | (111.80%) | (869.47%) | (84.32%) | (112.83%) | 49.44% |
Average Days of Receivables |
58.20 | 24.03 | 43.00 | 136,918.58 | 55,588.86 | 0.00 | 0.00 | 9,714.82 | 1,565.71 | 13,047.98 |
Research and Development Expense of Revenue |
324.71% | 647.11% | 756.89% | 421,186.57% | 431,308.77% | 0.00% | 0.00% | 4,511.50% | 1,739.00% | 16,239.08% |
Selling, General and Administrative Expense of Revenue |
114.33% | 262.99% | 333.45% | 151,617.91% | 186,675.44% | 0.00% | 0.00% | 5,909.51% | 1,719.13% | 17,964.71% |
Intangible Assets out of Total Assets |
0.36 | 0.47 | 0.38 | 0.40 | 0.55 | 0.45 | 0.04 | 0.02 | 0.04 | 0.00 |
Share Based Compensation of Revenue |
33.40% | 72.57% | 115.41% | 46,388.06% | 55,752.63% | 0.00% | 0.00% | 916.67% | 19.37% | 579.83% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | (0.01) | (0.16) | — | — | — | — | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(48.66%) | (39.16%) | (10.02%) | (42.35%) | (50.98%) | — | — | — | — | — |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | (49.97%) | (90.16%) | — | — | — | — | — |
Revenue per Share |
1.01 | 0.42 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(2.93) | (5.22) | (2.89) | (2.52) | (2.27) | (2.02) | (1.31) | (0.64) | (0.15) | (0.18) |
Capex per Share |
(0.20) | (0.10) | (0.18) | (0.06) | (0.01) | (0.03) | (0.01) | 0.02 | 0.00 | 0.08 |
Free Cash Flow per Share |
(3.14) | (5.32) | (3.07) | (2.58) | (2.27) | (2.05) | (1.31) | (0.62) | (0.15) | (0.10) |
Cash per Share |
9.81 | 3.98 | 5.27 | 3.52 | 1.41 | 2.28 | 0.58 | 0.29 | 0.11 | 0.04 |
Shareholders Equity per Share |
10.80 | 5.58 | 5.89 | 4.08 | 2.54 | 3.31 | 0.20 | 0.27 | 0.01 | 0.06 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
10.80 | 5.58 | 5.89 | 4.08 | 2.54 | 3.31 | 0.20 | 0.27 | 0.01 | 0.06 |
Free Cash Flow |
(29.21) | (51.20) | (34.18) | (32.28) | (31.70) | (31.99) | (29.64) | (16.01) | (6.26) | (4.40) |
Working Capital |
81.99 | 32.16 | 49.66 | 34.62 | 8.99 | 24.21 | 4.63 | 8.86 | 3.97 | 1.90 |
Capital Expenditures |
(1.89) | (0.97) | (2.00) | (0.70) | (0.10) | (0.46) | (0.13) | 0.44 | (0.11) | 3.40 |
Net Current Asset Value |
41.44 | 7.12 | 15.33 | (1.55) | (17.57) | (2.38) | (0.60) | 1.24 | (3.14) | 1.85 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Capex to Sales |
0.20 | 0.24 | 0.54 | 103.97 | 16.82 | 0.00 | 0.00 | (3.99) | 0.55 | (142.95) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.43 | 2.74 | 0.37 | 0.35 | 0.44 | 0.47 | 4.66 | 0.43 | 0.30 | 0.00 |
Cash ROIC |
(15.12%) | (54.94%) | (27.18%) | (32.70%) | (54.63%) | (35.86%) | (166.66%) | (104.12%) | (105.65%) | (93.94%) |
Accounts Receivable Turnover |
8.46 | 4.53 | 10.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.11 | 0.03 |
Accounts Payable Turnover |
0.01 | 0.08 | 0.00 | 0.00 | 0.00 | 0.26 | 0.24 | 0.02 | 0.01 | 0.01 |
Inventory Turnover |
0.00 | 0.00 | — | — | — | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
Average Days of Payables |
55,816.35 | 3,401.94 | 0.00 | 0.00 | 0.00 | 1,652.81 | 1,192.92 | 6,573.42 | 37,460.23 | 23,187.53 |
Days of Inventory on Hand |
4,209.27 | 0.00 | — | — | — | 0.00 | 0.00 | 0.00 | 12,668.31 | 0.00 |
Average Receivables |
1.11 | 0.88 | 0.35 | 1.47 | 1.69 | 1.65 | 1.81 | 2.06 | 1.90 | 0.86 |
Average Payables |
9.24 | 7.19 | 6.21 | 7.40 | 6.61 | 6.62 | 6.41 | 3.18 | 1.34 | 0.96 |
Average Inventory |
— | — | — | — | — | — | — | — | 0.56 | — |
Average Assets |
165.37 | 120.67 | 99.55 | 105.99 | 88.05 | 85.03 | 57.68 | 19.20 | 14.18 | 7.80 |
Average Common Equity |
112.18 | 77.15 | 59.69 | 58.37 | 43.25 | 43.52 | 28.09 | 5.69 | 3.69 | 1.66 |
Columns are period end dates · fundamentals updated 14 Oct 2026